At the level of key metabolic enzyme targeting, curcumin inhibits the mRNA expression of BCAT1 in human myeloid leukemia cell lines and bone marrow mononuclear cells derived from acute myeloid leukemia (AML) patients. This evidence concerns the gene BCAT1 and acute myeloid leukemia.